Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis

Blood

Volumn 89, Issue 4, 1997, Pages 1341-1348

  Sneller, Michael C ^a   Wang, Jin ^b   Dale, Janet K ^b   Strober, Warren ^b   Middelton, Lindsay A ^b   Choi, Youngnim ^b   Fleisher, Thomas A ^b   Lim, Megan S ^b   Jaffe, Elaine S ^b   Puck, Jennifer M ^b   Lenardo, Michael J ^b   Straus, Stephen E ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CLINICAL FEATURE; FOLLOW UP; GENE MUTATION; GENOTYPE; HELPER CELL; HUMAN; HUMAN CELL; HYPERGAMMAGLOBULINEMIA; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; SUPPRESSOR CELL; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; FEMALE; GENETICS; IMMUNOLOGY; INFANT; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NEUTROPENIA; PATHOLOGY; PEDIGREE; PHYSIOLOGY; PRESCHOOL CHILD; SYNDROME; T LYMPHOCYTE SUBPOPULATION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGAMMAGLOBULINEMIA; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MICE; NEUTROPENIA; PEDIGREE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLENOMEGALY; SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 0030614415     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1341     Document Type: Article

References (28)

1. Lenardo M: Fas and the art of lymphocyte maintenance. J Exp Med 183:721, 1996
2. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858, 1991
3. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak RA: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
4. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348, 1995
5. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
6. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994
7. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler SM, Strober W: A novel lymphoproliferative/autoimmune syndrome resembling murine Ipr/gld disease. J Clin Invest 90:334, 1992
8. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
9. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay J: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
10. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH: gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928, 1994
11. Gutierrez RJ, Andreu JL, Revilla Y, Vinuela E, Martinez C: Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 346:271, 1990
12. Mountz JD, Smith HR, Wilder RL, Reeves JP, Steinberg AD: CS-A therapy in MRL-lpr/lpr mice: Amelioration of immunopathology despite autoantibody production. J Immunol 138:157, 1987
13. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710, 1984
14. Cohen PL, Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243, 1991
15. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci U S A 90:4409, 1993
16. Shivakumar S, Tsokos G, Datta S: T cell receptor alpha/beta expressing double negative and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143:103, 1989
17. de la Hera A, Toribio M, Marquez C, C M: IL-2 promotes growth and cytolytic activity in human T3+4-8-thymocytes. Proc Natl Acad Sci USA 82:6268, 1985
18. Giese T, Davidson WF: In CDS+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220-T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol 154:4986, 1995
19. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557, 1995
20. Garrone P, Neidhardt EM, Garcia E, Galibert L, van KC, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265, 1995
21. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC: CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181, 1995
22. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513, 1995
23. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795, 1995
24. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
25. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze OK: Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81, 1995
26. Nagata S. Golstein P: The Fas death factor. Science 267:1449. 1995
27. Perillo N, Pace K, Seilhamer J, Baum L: Apoptosis of T cells mediated by galectin-1. Nature 378:736, 1995
28. Hsu H, Xiong J, Goeddel D: The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 81:495, 1995